'We Are On This Journey Together': Pele Backs Brazil Ahead Of World Cup Match


(MENAFN- The Peninsula) #qatar 2022 #world cup teams Reuters

Sao Paulo: Soccer great Pele on Monday backed Brazil's national team ahead of their World Cup round of 16 match against South Korea, saying he will watch the game from hospital after being admitted there last week as he battles colon cancer.

Pele, 82, said in an Instagram post that he wished to inspire Brazil's players by sharing a picture taken at the 1958 World Cup in Sweden, when the then-teenager shocked the world leading the South American side to their first title.

'I'll watch the game from here at the hospital and I'll be rooting for each one of you,' Pele said ahead of the match starting at 1900 GMT in Qatar.

'We are on this journey together. Good luck to our Brazil!'

Internationally revered as one of the greatest footballers of all time -- if not the greatest -- Pele had a tumor removed from his colon in September 2021 and has been receiving hospital care on a regular basis.

Read Also
  • worried fans keep vigil outside brazil clinic of football icon pele
  • brazil football legend pele in stable condition amid cancer battle, hospital says
  • world cup lights up to show support for hospitalised pele

He was hospitalized last week to re-evaluate his treatment and is also being treated for a respiratory infection, according to medical reports.

Pele played for Brazil and club sides Santos and New York Cosmos as a striker. He helped lead his country to three World Cup championships three times - in 1958, 1962 and 1970 - a feat no other player has achieved.

Brazil are seeking to win a record-extending sixth world title.

MENAFN05122022000063011010ID1105269919


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.